Skip to main content
OpenTrials
Completed

NCT Number: NCT03423836

Maternal Oral Therapy to Reduce Obstetric Risk Kids

The principal objective was to conduct a 5 year; multi-center, observational follow-up study enrolling infants born to mothers who participated in the MOTOR clinical trial to determine the effects of maternal periodontal therapy during pregnancy on neonatal morbidity and mortality and whether this will result in lower incidence of functional neurological impairment.

Completed

Looking for future studies?

Notify Me

Key information

Age range

1 day and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Alabama at Birmingham Department of Ostetrics and Gynecology, Birmingham, Alabama, United States

Loading trial locations.

About this study

A total of 525 infants where planned to be enrolled at the 3 performance sites. The number of infants enrolled at each site depended on past Motor recruitment rates, and the observed delivery rate of high risk babies at that site. Infants were enrolled from both the high risk and low risk groups. The intended sample size was fixed, over sampling among the low risk group and was used to assure the sample size.

The Data Coordinating Center (DCC) identified and provided each clinical site with participant listings of all MOTOR high risk births and a randomly ordered sample of low risk births for enrollment into the study.

Mothers where approached by MOTOR or MOTORkids personnel to ascertain participant interest in enrolling their infant. Once consent was obtained, infants were followed and tracked until scheduled for the follow-up exams at age 24 months +/- 2 months adjusted age.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All infants born to mothers enrolled to MOTOR study prior to 35 weeks gestational age,
  • All small for gestational age (SGA) infants and all infants born after 37 weeks gestation and who were appropriate for gestational age are eligible for enrollment.
  • All infants born < 34 weeks gestation and all SGA infants will be considered a high risk infant and will be recruited for enrollment.
  • Appropriate weight for gestational age infants born after 37 weeks will be considered low risk infants and a random sample of these infants will be recruited for enrollment.

Exclusion criteria

  • Only a random sample of the low risk group will be recruited.

Treatment and study plan

Primary outcomes

  1. MCHAT Score

    Time frame: 24 months

    MCHAT composite risk score for Autism questionnaire is a 20-item screening tool completed by parents of children aged 16-30 months to evaluate Autism Spectrum Disorder (ASD) risk. Score ranges include 0 to 20 with 2 or less indicating low-risk, 3-7 medium-risk and 8-20 indicating high-risk.

Sponsors and collaborators

Lead sponsor

University of North Carolina, Chapel Hill

Other

Collaborators

  • National Institute of Dental and Craniofacial Research (NIDCR)

Registry information

Acronym: MOTORKids

Important dates

Study start
2007
Primary completion
2010
Study completion
2013
First posted
Feb 6, 2018
Registry last updated
Feb 14, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.